1 |
顾晋,杜敬曾.客观评价和正确开展结直肠癌的新辅助治疗[J].中国实用外科杂志, 2011, 31(1): 47-49.
|
2 |
王锡山.结直肠癌综合治疗的规范化实施[J].中国实用外科杂志, 2010, 30(4): 260-264.
|
3 |
中华人民共和国卫生和计划生育委员会医政医管局,中华医学会肿瘤学会分会.中国结直肠癌诊疗规范(2015版)[J/CD].中华普通外科学文献:电子版, 2015, 9(6): 506-523.
|
4 |
Hompes D,Aalbers A,Boot H, et al. A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal car-cinomatosis from colorectal cancer[J]. Colorectal Dis, 2014, 16(8): 264-272.
|
5 |
Inoue Y,Tanaka R,Komeda K, et al. Fluorescence detection of malignant liver tumors using 5-aminolevulinic acid-mediated photodynamic diagnosis: principles, technique, and clinical expe-rience[J]. World J Surg, 2014, 38(7): 1786-1794.
|
6 |
Sclafani F,Gonzalez D,Cunningham D, et al. RAS mutations and cetuximab in locally advanced rectal cancer: results of the EX-PERT-C trial[J]. Eur J Cancer, 2014, 50(8): 1430-1436.
|
7 |
Dede K,Salamon F,Landherr L, et al. Pathologic assessment of response to chemotherapy in colorectal cancer liver metastases af-ter hepatic resection: which method to use?[J]. Pathol Oncol Res, 2015, 21(1): 173-179.
|
8 |
Cokmert S,Ellidokuz H,Demir L, et al. Survival outcomes of liv-er metastasectomy in colorectal cancer cases: a single-center analysis in Turkey[J]. Asian Pac J Cancer Prev, 2014, 15(13):5195-5200.
|
9 |
Landry JC,Feng Y,Cohen SJ, et al. Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevaci-zumab followed by surgery and postoperative 5-fluorouracil, leu-covorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204[J]. Cancer, 2013, 119(8): 1521-1527.
|
10 |
Simpson AL,Leal JN,Pugalenthi A, et al. Chemotherapy-in-duced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorec-tal cancer[J]. J Am Coll Surg, 2015, 220(3): 271-280.
|
11 |
Sutton P,Evans J,Jones R, et al. Proteomic analysis to identify biomarkers in the primary tumour that predict response to neoad-juvant chemotherapy in liver metastases[J]. Lancet, 2015, 385 Suppl 1: S95.
|
12 |
赵长林.结直肠癌肝转移转化治疗的相关问题[J/CD].中华普通外科学文献:电子版, 2014, 8(3): 181-184.
|
13 |
王林,顾晋.直肠恶性肿瘤的新辅助治疗:研究现状与外科决策[J/CD].中华普通外科学文献:电子版, 2014, 8(6): 176-180.
|
14 |
Osada S,Imai H,Sasaki Y, et al. Surgical indications for multiple and synchronous liver metastases from colorectal cancer[J]. Hepatogastroenterology, 2014, 61(131): 722-726.
|
15 |
Huang L,Li TJ,Zhang JW, et al. Neoadjuvant chemotherapy followed by surgery versus surgery alone for colorectal cancer: meta-analysis of randomized controlled trials[J]. Medicine (Baltimore), 2014, 93(28): e231.
|
16 |
Desurmont T,Skrypek N,Duhamel A, et al. Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metasta-ses from colon cancer is correlated to shorter disease-free and overall survival[J]. Cancer Sci, 2015, 106(3): 262-269.
|
17 |
Liu L,Zheng W,Song Y, et al. miRNA-497 Enhances the Sensi-tivity of Colorectal Cancer Cells to Neoadjuvant Chemotherapeu-tic Drug[J]. Curr Protein Pept Sci, 2015,16(4): 310-315.
|
18 |
Khan K,Wale A,Brown G, et al. Colorectal cancer with liver me-tastases: neoadjuvant chemotherapy, surgical resection first or pal-liation alone?[J]. World J Gastroenterol, 2014, 20(35): 12391-12406.
|
19 |
Elebro J,Heby M,Gaber A, et al. Prognostic and treatment pre-dictive significance of SATB1 and SATB2 expression in pancreat-ic and periampullary adenocarcinoma[J]. J Transl Med, 2014, 12: 289.
|